Mayer Fishman is an Oncology physician affiliated with Tampa General Hospital. OpenAlex indexes 265 publications with 9,615 citations (h-index 45); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12902 Usf Magnolia Dr
Gu Program
Tampa, FL 336129416
Telephone
813-745-8343Registry record last updated 3 Oct 2014.
Clinical trials
- Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
- Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma Global DevelopmentProgram year20251 payment
- PFIZER INC.Program year20256 payments
- Eisai Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2008–2009 per NIH RePORTER. The latest:
- Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients
H. Lee Moffitt Cancer Ctr & Res Inst
FY2009$201,603R01FD003452 - Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients
H. Lee Moffitt Cancer Ctr & Res Inst
FY2009$63,244R01FD003452 - Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients
H. Lee Moffitt Cancer Ctr & Res Inst
FY2008$193,715R01FD003452
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Rodney Landreneau, MD
Tampa General Hospital
Hiram Bezerra, MD
Tampa General Hospital
Hartmuth Bittner, MD
Tampa General Hospital
Nyingi Kemmer, MD
Tampa General Hospital
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”